Citadel Advisors - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 34 filers reported holding AGEX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,559
+7.4%
10,702
-20.3%
0.00%
Q1 2023$8,898
+48.3%
13,421
+33.8%
0.00%
Q3 2022$6,000
-33.3%
10,029
-37.4%
0.00%
Q2 2022$9,000
-76.3%
16,017
-60.5%
0.00%
Q3 2021$38,000
+90.0%
40,537
+65.5%
0.00%
Q3 2020$20,000
+81.8%
24,489
+118.0%
0.00%
Q2 2020$11,000
-21.4%
11,234
-26.7%
0.00%
Q1 2020$14,00015,3350.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 2,997,156$5,455,0000.63%
Defender Capital, LLC. 138,192$251,0000.22%
Beirne Wealth Consulting Services, LLC 12,000$22,0000.02%
Prescott General Partners LLC 185,185$337,0000.02%
Iowa State Bank 11,000$20,0000.01%
Sigma Planning Corp 38,750$71,0000.00%
Silicon Hills Wealth Management, LLC 1$1,0000.00%
PANAGORA ASSET MANAGEMENT INC 80,225$146,0000.00%
Riggs Asset Managment Co. Inc. 1,160$2,0000.00%
Pacifica Partners Inc. 292$1,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders